Cross-neutralizing crf01_ae-infected plasma from Malaysia targets cd4-binding site of human immunodeficiency virus type-1 envelope glycoprotein
Human immunodeficiency virus type-1 (HIV-1) antigenic variation poses a great challenge for vaccine immunogen design to elicit broadly neutralizing antibodies (bNAbs). Over the last 10-15 years, great progress has been made to understand the conserved sites of sensitivity on HIV envelope glycoprotei...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Mary Ann Liebert, Inc
2022
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/33817/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|